PT  - JOURNAL ARTICLE
AU  - Gillis, Grace
AU  - Bhalerao, Gaurav
AU  - Blane, Jasmine
AU  - Mitchell, Robert
AU  - Pretorius, Pieter M
AU  - McCracken, Celeste
AU  - Nichols, Thomas E
AU  - Smith, Stephen M
AU  - Miller, Karla L
AU  - Alfaro-Almagro, Fidel
AU  - Raymont, Vanessa
AU  - Martos, Lola
AU  - Mackay, Clare E
AU  - Griffanti, Ludovica
TI  - From Big Data to the clinic: methodological and statistical enhancements to implement the UK Biobank imaging framework in a memory clinic
AID  - 10.1101/2024.08.02.24311402
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.08.02.24311402
4099  - http://medrxiv.org/content/early/2024/08/13/2024.08.02.24311402.short
4100  - http://medrxiv.org/content/early/2024/08/13/2024.08.02.24311402.full
AB  - Introduction The analysis tools and statistical methods used in large neuroimaging research studies differ from those applied in clinical contexts, making it unclear whether these techniques can be translated to a memory clinic setting. The Oxford Brain Health Clinic (OBHC) was established in 2020 to bridge this gap between research studies and memory clinics.Methods We optimised the UK Biobank imaging framework for the memory clinic setting by integrating enhanced quality control (QC) processes (MRIQC, QUAD, and DSE decomposition) and supplementary dementia-informed analyses (lobar volumes, NBM volumes, WMH classification, PSMD, cortical diffusion MRI metrics, and tract volumes) into the analysis pipeline. We explored associations between resultant imaging-derived phenotypes (IDPs) and clinical phenotypes in the OBHC patient population (N=213), applying hierarchical FDR correction to account for multiple testing.Results 14-24% of scans were flagged by automated QC tools, but upon visual inspection, only 0-2.4% of outputs were excluded. The pipeline successfully generated 5683 IDPs aligned with UK Biobank and 110 IDPs targeted towards dementia-related changes. We replicated established associations and found novel associations between brain metrics and age, cognition, and dementia-related diagnoses.Conclusion The imaging protocol is feasible, acceptable, and yields high-quality data that is usable for both clinical and research purposes. We validated the use of this methodology in a real-world memory clinic population, which demonstrates the potential of this enhanced pipeline to bridge the gap between big data studies and clinical settings.Key PointsThe imaging methods, analysis techniques, and population characteristics in research studies often differ to those in traditional clinical settings.To bridge this gap, we optimised the UK Biobank imaging framework for memory clinic use by integrating enhanced quality control (QC) and supplementary analyses targeted towards dementia-related changes.We generated 5683 imaging-derived phenotypes (IDPs) aligned with UK Biobank and 110 supplementary dementia-informed IDPs that captured both established and novel associations between brain metrics and dementia-related clinical phenotypes, highlighting the value of integrating UK Biobank-aligned imaging and analyses in a real-world memory clinic population.Competing Interest StatementCEM is a cofounder and shareholder of Exprodo Software, which was used to develop the OBHC database. CEM serves on a Biogen Brain Health Consortium (unpaid). No other competing interests to report.Clinical Protocols https://bmjopen.bmj.com/content/13/8/e067808 Funding StatementThis project was supported by the National Institute for Health and Care Research (NIHR) Oxford Health Biomedical Research Centre (NIHR203316), the NIHR Oxford Cognitive Health Clinical Research Facility, and the Wellcome Centre for Integrative Neuroimaging. The Wellcome Centre for Integrative Neuroimaging is supported by core funding from the Wellcome Trust (203139/Z/16/Z). The views expressed are those of the author(s) and not necessarily those of the NIHR or Department of Health and Social Care. LG is supported by an Alzheimer's Association Grant (AARF-21-846366). JB is supported by the Medical Research Council (MR/N013468/1). CM is supported by the NIHR Oxford Biomedical Research Centre. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the Health Research Authority (South Central, Oxford C (SC/19/0404)) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe complete OBHC MRI protocol and scanning procedure is available through the WIN MR Protocols Database at: https://open.win.ox.ac.uk/protocols/stable/6974395a-3745-4861-b8cc-1887e787d1c4 (O’Donoghue et al., 2022b).The UKB-dementia pipeline presented here and used for this analysis is openly available (https://git.fmrib.ox.ac.uk/open-science/analysis/brain-health-clinic-mri) along with the original UK Biobank brain MRI analysis pipeline (https://git.fmrib.ox.ac.uk/falmagro/uk_biobank_pipeline_v_1.5/-/tree/master).Additional scripts used for OBHC analyses are also available (https://git.fmrib.ox.ac.uk/gillisc/01_bhc_imaging.git). Interactive versions of the figures are available (https://users.ox.ac.uk/~scat8503/).The MRI data presented in this paper will be available via the Dementias Platform UK (https://portal.dementiasplatform.uk/CohortDirectory/Item?fingerPrintID=BHC), and access will be granted through an application process, reviewed by the OBHC Data Access Group. The OBHC Data Access Group will start accepting applications to access OBHC data upon publication of the present work. Data will continue to be released in batches as the OBHC progresses in order to minimise the risk of participant identification.